catheter
A silicone rubber Foley catheter with a silane coupling agent and crosslinked polyurethane network water-soluble polymer layer addresses the issue of lubricity loss, ensuring long-term comfort and reduced friction.
Patent Information
- Application Number
- JP2021131975
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-08-13
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-08-13
AI Technical Summary
Foley catheters experience a reduction in lubricity over time due to peeling of the hydrophilic layer, necessitating improved long-term lubricity maintenance.
A catheter structure comprising a silicone rubber tube with a silane coupling agent layer and a water-soluble polymer layer containing a crosslinked polyurethane network, where the silane coupling agent layer enhances adhesion and the water-soluble polymer layer maintains lubricity over time.
The catheter maintains lubricity over a prolonged period, reducing friction and discomfort during use.
Smart Images

Figure 0007581155000001 
Figure 0007581155000002
Abstract
Description
[Technical field]
[0001] The present invention relates to a catheter. [Background technology]
[0002] In the medical field, for example, Foley catheters are used for the purpose of catheterization of patients who have difficulty urinating, catheterization during surgery or absolute rest, measurement of residual urine volume, etc. A Foley catheter is used by passing a flexible tube part through the urethra, and after insertion, inflating the balloon at the tip in the bladder to leave it in place. A Foley catheter is usually made of silicone or the like, and is required to have low friction on the surface part so as not to damage the urethra. In response to such requirements, a method of forming a coating containing a water-soluble polymer that imparts lubricity to the surface of a catheter is known. For example, Patent Document 1 discloses a method of forming an interpolymer of polyvinylpyrrolidone and polyurethane on the surface. Patent Document 2 discloses providing a hydrophilic layer containing a water-soluble polymer on the surface of a resin molded part of a medical device, and an intermediate layer containing an isocyanate compound, a vinyl compound, etc., in order to improve the adhesion between the resin molded part and the hydrophilic layer. Furthermore, it is disclosed that a silane coupling agent is contained in the resin molded part and the surface of the resin molded part is UV-treated to strengthen the adhesion between the resin molded part and the intermediate layer. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] Japanese Patent Application Publication No. 5-156203 [Patent Document 2] JP 2019-72103 A Summary of the Invention [Problem to be solved by the invention]
[0004] However, the hydrophilic layer on the surface may peel off after long-term use, reducing the lubricity of the catheter. For this reason, further improvements are required to maintain lubricity over a long period of time in catheters having a hydrophilic layer. The present invention has been made in consideration of the above circumstances, and an object of the present invention is to provide a catheter that has lubricity for a long period of time. [Means for solving the problem]
[0005] The catheter of the present invention has a catheter tube made of silicone rubber, and is provided with a silane coupling agent layer and a water-soluble polymer layer containing a crosslinked polyurethane network, in that order, on the outer periphery of the catheter tube.
[0006] The silane coupling agent layer preferably contains a silane coupling agent having at least one of an amino group and an isocyanate group.
[0007] The content of the crosslinked polyurethane network is preferably 50% by weight or less based on the total weight of the water-soluble polymer in the water-soluble polymer layer. Effect of the Invention
[0008] The catheter of the present invention maintains lubricity for a long period of time. [Brief description of the drawings]
[0009] [Figure 1] 1 is a plan view showing a balloon catheter according to one embodiment of the present invention. FIG. [Diagram 2] 2 is a cross-sectional view taken along line AA in FIG. 1. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Hereinafter, an embodiment of a catheter according to the present invention will be described with reference to the drawings. The following embodiment is presented for illustrative purposes, and the present invention is not limited to the embodiment shown below.
[0011] [catheter] 1 and 2, the catheter 10 of this embodiment is a Foley catheter, which is provided with a silane coupling agent layer 20 and a water-soluble polymer layer 30 containing a cross-linked polyurethane network, in this order, on the outer periphery of a catheter tube 11. The catheter tube 11 is provided at its tip with a side hole 12 for taking in urine and a balloon portion 19. The catheter tube 11 has a first lumen 14 and a second lumen 15 inside. The first lumen 14 is an internal connecting hole that communicates with the side hole 12. Urine in the bladder taken in from the side hole 12 is discharged to a urine collection bag (not shown) through a urination funnel 18. The second lumen 15 is an internal connecting hole through which a medium for inflating the balloon tube (not shown), such as physiological saline, sterilized purified water, air, etc., is fed and discharged. The second lumen 15 has a through hole 13 that extends from the inside of the second lumen 15 to the outer wall of the catheter tube 11. For example, air is pressurized into the second lumen 15 by a valve 17, and the pressurized air is supplied between the catheter tube 11 and the balloon tube (not shown) through the through hole 13 from the second lumen 15. As a result, the balloon tube expands and the air is retained inside to form a balloon.
[0012] The catheter tube 11 may have a side surface provided with a contrast portion 16 in which a contrast agent is blended linearly along the longitudinal direction X.
[0013] <Catheter tube> The catheter tube 11 is made of silicone rubber. From the viewpoint of reducing pain during insertion into the body, the rubber hardness (JIS K 6253-3) of the catheter tube 11 is preferably A30 or more and A80 or less, and more preferably A40 or more and A70 or less.
[0014] The catheter tube 11 can be produced by subjecting a silicone rubber composition to primary extrusion molding and vulcanization treatment. The primary extrusion molding can be carried out using a known horizontal extruder or vertical extruder. In the extrusion molding process and vulcanization treatment, it is preferable to use a vertical extruder and vulcanizer. By using a vertical extruder and vulcanizer, minute contact marks are not left on the surface of the tube, so that eccentricity does not occur when the balloon is inflated, and the balloon can be prevented from bursting. The silicone rubber composition may be, for example, an addition curing type millable silicone rubber composition. The silicone rubber composition may contain a curing agent such as a crosslinking agent or a catalyst. .
[0015] (Modification treatment) The surface 11a of the catheter tube 11 is preferably modified before forming the silane coupling agent layer 20. As the modification, low pressure mercury UV irradiation treatment, excimer UV irradiation treatment, plasma treatment, etc., which can replace the methyl group, which is a substituent of silicone rubber, with a hydroxyl group, are preferable. By replacing with a hydroxyl group, a covalent bond is formed by a dehydration condensation reaction with the hydroxyl group generated by the hydrolysis reaction of the silane coupling agent described later. This strengthens the adhesion between the silane coupling agent layer 20 and the catheter tube 11.
[0016] <Silane coupling agent layer> The silane coupling agent layer 20 serves to bond the catheter tube 11 and the water-soluble polymer layer 30, and can be formed by applying a composition containing a silane coupling agent and an organic solvent described below, followed by crosslinking and drying.
[0017] A silane coupling agent is an organosilicon compound having a reactive group that chemically bonds with one or more organic materials and a reactive group that chemically bonds with two or more inorganic materials. Examples of reactive groups that chemically bond with organic materials include vinyl groups, epoxy groups, styryl groups, methacryl groups, acrylic groups, amino groups, isocyanate groups, ureido groups, and mercapto groups. Among them, silane coupling agents having at least one of amino groups and isocyanate groups are preferred in consideration of bonding with isocyanate groups that are not used to generate polyurethane. Examples of reactive groups that chemically bond with inorganic materials include alkoxy groups such as methoxy groups and ethoxy groups.
[0018] Specific examples of the silane coupling agent include vinyltrimethoxysilane, vinyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, p-styryltrimethoxysilane, 3-methacryloxypropylmethyldimethoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyltrimethoxysilane, Examples of the silane include N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylidene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, N-(vinylbenzyl)-2-aminoethyl-3-aminopropyltrimethoxysilane hydrochloride, 3-ureidopropyltrialkoxysilane, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, and 3-isocyanatopropyltriethoxysilane. Among these, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylidene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, N-(vinylbenzyl)-2-aminoethyl-3-aminopropyltrimethoxysilane hydrochloride, and 3-isocyanatopropyltriethoxysilane are particularly preferred.
[0019] - Organic solvents - The organic solvent to be selected must be one that does not react with the silane coupling agent and can dissolve it.
[0020] The thickness of the silane coupling agent layer 20 is preferably 0.1 μm or more and 5.0 μm or less.
[0021] The silane coupling agent layer 20 can be formed by applying a composition of a silane coupling agent and an organic solvent to the outer periphery of the catheter tube 11, followed by crosslinking and drying.
[0022] <Water-soluble polymer layer> The water-soluble polymer layer 30 can be formed by applying a composition for forming a water-soluble polymer layer, which contains a polyol, a polyisocyanate, a water-soluble polymer, and an organic solvent, followed by crosslinking and drying. The water-soluble polymer layer 30 contains a crosslinked polyurethane network in the water-soluble polymer. By having such a structure, the surface of the catheter 10 can maintain lubricity for a long period of time.
[0023] The composition for forming a water-soluble polymer layer can be applied by a roll coating method, a dipping method, etc. As shown in Fig. 1, in the case of a catheter having a balloon portion 19, a balloon tube constituting the balloon portion 19 is attached to a catheter tube 11, a composition of a silane coupling agent and an organic solvent is applied, crosslinked and dried to form a silane coupling agent layer 20, and a composition for forming a water-soluble polymer layer is further applied thereon, crosslinked and dried to form a water-soluble polymer layer 30.
[0024] (Water-soluble polymer layer forming composition) The components of the water-soluble polymer layer-forming composition will be described below.
[0025] -Polyol- The polyol may be any of various polyols that are commonly used in the preparation of polyurethanes, and is preferably at least one polyol selected from polyether polyols, polyester polyols, polyacrylate polyols, and polycarbonate polyols.
[0026] Examples of polyether polyols include polyalkylene glycols such as polyethylene glycol, polypropylene glycol, and polypropylene glycol-ethylene glycol, polytetramethylene ether glycol, copolymer polyols of tetrahydrofuran and alkylene oxide, various modified products thereof, and mixtures thereof.
[0027] The polyester polyol has two or more ester bonds and two or more hydroxyl groups in the molecule. Examples of the polyester polyol include condensation products of dicarboxylic acids and polyols. Examples of the dicarboxylic acids include aromatic dicarboxylic acids such as phthalic acid, terephthalic acid, and isophthalic acid, and aliphatic dicarboxylic acids such as adipic acid and sebacic acid.
[0028] Polyacrylate polyols are copolymers of hydroxyl-containing monomers with other olefinically unsaturated monomers, such as esters of (meth)acrylic acid, styrene, α-methylstyrene, vinyl toluene, vinyl esters, mono- and dialkyl maleates, mono- and dialkyl fumarate esters, α-olefins and other unsaturated oligomers and polymers.
[0029] Polycarbonate polyol has two or more carbonate bonds and two or more hydroxyl groups in a molecule. Examples of polycarbonate polyols include condensation reaction products of polyols and carbonate compounds. Examples of carbonate compounds include dialkyl carbonates, diaryl carbonates, and alkylene carbonates. Examples of polyols used as raw materials for polycarbonate polyols include diols such as hexanediol and butanediol, and triols such as 2,4-butanetriol. From the viewpoint of excellent compatibility with isocyanates and the like described below, the polyol preferably has a number average molecular weight of 1000 to 8000, and more preferably has a number average molecular weight of 1000 to 5000. The number average molecular weight is the molecular weight calculated in terms of standard polystyrene by gel permeation chromatography (GPC).
[0030] -Polyisocyanate- Examples of the polyisocyanate include polyisocyanate monomers, polyisocyanate derivatives, etc. Examples of the polyisocyanate monomers include polyisocyanates such as aromatic polyisocyanates, araliphatic polyisocyanates, aliphatic polyisocyanates, and alicyclic polyisocyanates.
[0031] Examples of aromatic polyisocyanates include aromatic diisocyanates such as tolylene diisocyanate (2,4- or 2,6-tolylene diisocyanate or a mixture thereof) (TDI), phenylene diisocyanate (m-, p-phenylene diisocyanate or a mixture thereof), 4,4'-diphenyl diisocyanate, 1,5-naphthalene diisocyanate (NDI), diphenylmethane diisocyanate (4,4'-, 2,4'-, or 2,2'-diphenylmethane diisocyanate or a mixture thereof) (MDI), 4,4'-toluidine diisocyanate (TODI), and 4,4'-diphenyl ether diisocyanate.
[0032] Examples of the aromatic aliphatic polyisocyanate include aromatic aliphatic diisocyanates such as xylylene diisocyanate (1,3- or 1,4-xylylene diisocyanate or a mixture thereof) (XDI), tetramethyl xylylene diisocyanate (1,3- or 1,4-tetramethyl xylylene diisocyanate or a mixture thereof) (TMXDI), and ω,ω'-diisocyanato-1,4-diethylbenzene.
[0033] Examples of the aliphatic isocyanate compound include hexamethylene diisocyanate (HDI), trimethylhexamethylene diisocyanate (TMHDI), lysine diisocyanate, norbornene diisocyanate methyl (NBDI), xylylene diisocyanate (XDI), tetramethylxylylene diisocyanate (TMXDI), etc. Examples of the alicyclic isocyanate include transcyclohexane-1,4-diisocyanate, isophorone diisocyanate (IPDI), H6XDI (hydrogenated XDI), H12MDI (hydrogenated MDI), 4,4'-dicyclohexylmethane diisocyanate, etc.
[0034] Examples of alicyclic polyisocyanates include 1,3-cyclopentane diisocyanate, 1,3-cyclopentene diisocyanate, cyclohexane diisocyanate (1,4-cyclohexane diisocyanate, 1,3-cyclohexane diisocyanate), 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate (isophorone diisocyanate) (IPDI), methylene bis(cyclohexyl isocyanate) (4,4'-, 2,4'- or 2,2'-methylene bis(cyclohexyl isocyanate, their trans,trans-isomer, trans,cis-isomer, cis,cis-isomer, or a mixture thereof)) (H 12 Examples of suitable polyisocyanate monomers include alicyclic diisocyanates such as methylcyclohexane diisocyanate (methyl-2,4-cyclohexane diisocyanate, methyl-2,6-cyclohexane diisocyanate), norbornane diisocyanate (various isomers or mixtures thereof) (NBDI), and bis(isocyanatomethyl)cyclohexane (1,3- or 1,4-bis(isocyanatomethyl)cyclohexane or mixtures thereof) (H6XDI). These polyisocyanate monomers can be used alone or in combination of two or more types.
[0035] Examples of the polyisocyanate derivative include multimers of the above-mentioned polyisocyanate monomers (e.g., dimers, trimers (e.g., isocyanurate-modified products, iminooxadiazinedione-modified products), pentamers, heptamers, etc.), allophanate-modified products (e.g., allophanate-modified products produced by the reaction of the above-mentioned polyisocyanate monomers with low-molecular-weight polyols described below), polyol-modified products (e.g., polyol-modified products (alcohol adducts) produced by the reaction of the polyisocyanate monomers with low-molecular-weight polyols described below), biuret-modified products (e.g., , biuret modified products produced by the reaction of the above-mentioned polyisocyanate monomer with water or amines), urea modified products (for example, urea modified products produced by the reaction of the above-mentioned polyisocyanate monomer with diamine), oxadiazinetrione modified products (for example, oxadiazinetrione produced by the reaction of the above-mentioned polyisocyanate monomer with carbon dioxide), carbodiimide modified products (carbodiimide modified products produced by the decarboxylation condensation reaction of the above-mentioned polyisocyanate monomer), uretdione modified products, uretonimine modified products, and the like. Further, examples of polyisocyanate derivatives include polymethylene polyphenyl polyisocyanate (crude MDI, polymeric MDI). These polyisocyanate derivatives can be used alone or in combination of two or more kinds. The above polyisocyanate compounds can be used alone or in combination of two or more kinds. Furthermore, the polyisocyanate used in the present invention may be a blocked polyisocyanate.
[0036] The composition for forming a water-soluble polymer layer may contain an auxiliary agent that is usually used in the reaction between a polyol and a polyisocyanate, such as a chain extender, a crosslinking agent, etc. Examples of the chain extender and the crosslinking agent include glycols, hexanetriol, trimethylolpropane, and amines.
[0037] The mixing ratio of the polyol and polyisocyanate in the mixture is preferably such that the molar ratio (NCO / OH) of the hydroxyl group (OH) contained in the polyol to the isocyanate group (NCO) contained in the polyisocyanate is 0.7 or more and 1.15 or less. This molar ratio (NCO / OH) is more preferably 0.85 or more and 1.10 or less in order to prevent hydrolysis of polyurethane. In practice, however, it is acceptable to mix in an amount equivalent to 3 to 4 times the appropriate molar ratio in consideration of the working environment and operational errors. The content of the crosslinked polyurethane network is preferably 50% by mass or less, more preferably 30% by mass or less, and even more preferably 10% by mass or less, based on the total mass of the water-soluble polymer in the water-soluble polymer layer.
[0038] -Water-soluble polymer- Water-soluble polymers include, but are not limited to, polyethylene oxide (PEO), polyethylene glycol (PEG), polysaccharides, hyaluronic acid and its salts and derivatives, sodium alginate, chondroitin sulfate, cellulose, chitin, chitosan, agarose, xanthan, dermatan sulfate, keratin sulfate, emilsan, gellan, curdlan, amylose, carrageenan, amylopectin, dextran, glycogen, starch, heparin sulfate, and limit dextrin and fragments thereof, synthetic hydrophilic polymers, poly(vinyl alcohol), and polyvinylpyrrolidone (PVP). A preferred water-soluble polymer for use in the present invention is polyvinylpyrrolidone. The water-soluble polymer layer 30 may contain one type of water-soluble polymer, or two or more types of water-soluble polymers.
[0039] - Organic solvents - The composition for forming a water-soluble polymer layer preferably contains an organic solvent. The organic solvent must not react with the polyol, polyisocyanate, and water-soluble polymer, but must be able to dissolve them all. The organic solvent preferably does not contain reactive amine, hydroxyl, and carboxyl groups. Specifically, the organic solvent is selected from the group consisting of methylene bromide, methylene chloride, dibromide methane, chloroform, dichloroethane, n-propyl bromide, acetonitrile, dibromide ethane, methyl benzyl acetate, n-propyl bromide, cyclohexanone, dichloroethylene, 1,3-dioxolane, and N-methylpyrrolidone.
[0040] The composition for forming a water-soluble polymer layer may contain other components in addition to the polyol, polyisocyanate, water-soluble polymer, and organic solvent. Examples of the other components include a catalyst and an antioxidant.
[0041] -catalyst- Non-limiting examples of suitable catalysts include tertiary amines such as N,N-dimethylaminoethanol, N,N-dimethyl-cyclohexamine-bis(2-dimethylaminoethyl)ether, N-ethylmorpholine, N,N,N',N',N"-pentamethyl-diethylene-triamine, and 1-2(hydroxypropyl)imidazole, as well as metal catalysts such as tin, tin octoate, dibutyltin dilaurate, dioctyltin dilaurate, dibutyltin mercaptide, ferric acetylacetonate, lead octoate, dibutyltin diricinoleate, calcium carbonate, iron(III) acetylacetonate, and the like. Preferred catalysts are dibutyltin diricinoleate and tin. The most preferred catalyst is dioctyltin dilaurate. The catalyst is preferably present in the polyol and blocked polyisocyanate in an amount ranging from 0.05% by weight to 0.5% by weight.
[0042] -Antioxidants- The antioxidant is effective in improving the oxidation stability of the cured coating. Examples of the antioxidant include, but are not limited to, vitamin E, tris(3,5-di-t-butyl-4-hydroxybenzyl)isocyanurate, 2,2'-methylenebis(4-methyl-6-t-butylphenol), 1,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)benzene, butylhydroxytoluene, octadecyl 3,5,di-t-butyl 4-hydroxyhydrocinnamate, 4,4'methylenebis(2,6-di-t-butylphenol), p,p'-dioctyldiphenylamine, and 1,1,3-tris-(2-methyl-4-hydroxy-5-t-butylphenyl)butane. The antioxidant is preferably present in an amount of 0.01% by mass or more and 1% by mass or less based on 100% by mass of the total of the polyol and the blocked polyisocyanate.
[0043] From the viewpoint of maintaining lubricity for a long period of time, the thickness of the water-soluble polymer layer 30 is preferably 5 μm or less, and more preferably 2 μm or less.
[0044] The catheter of the present invention may be a catheter that does not have a balloon portion 19. In that case, it is preferable to form a silane coupling agent layer and a water-soluble polymer layer containing a crosslinked polyurethane network in this order on the outer periphery of the catheter tube 11. [Explanation of symbols]
[0045] 10 Foley Catheter 11 Catheter tube 12 side hole 13 Through hole 14 First Lumen 15 Second Lumen 16 Contrast area 17 Valve 18 Urinary funnel 19 Balloon Section 20 Silane coupling agent layer 30 Water-soluble polymer layer
Claims
1. A catheter having a catheter tube made of silicone rubber, a silane coupling agent layer and a water-soluble polymer layer including a crosslinked polyurethane network are provided on an outer periphery of the catheter tube in this order; A catheter, wherein the content of the crosslinked polyurethane network is 10% by mass or less based on the total mass of the water-soluble polymer in the water-soluble polymer layer.
2. 2. The catheter according to claim 1, wherein the silane coupling agent layer contains a silane coupling agent having at least one of an amino group and an isocyanate group.
Citation Information
Patent Citations
Smooth hydrogel coating
JP1993156203A
antibacterial coating
JP2009528855A
Medical appliance
JP2019072103A
